“fda” Archives

in
Entry Author Date Location
FDA OKs Eczema Injection; Owners Regeneron, Sanofi Set $37K Price 03/28/17 New York
Tesaro’s Ovarian Cancer Drug Gets FDA Nod, No Diagnostic Needed 03/27/17 Boston
After $1M NEI Grant, ONL Therapeutics Closer to Clinical Trials 03/27/17 Detroit Ann Arbor
Ionis Pharma Spins Out Lipid Disorder Unit Akcea with Plans for IPO 03/27/17 Boston
Texas Roundup: SXSW Odds & Ends, Dosh, Mythic, Peloton, & More 03/22/17 Texas
BioClin Gets $30M to Back More Bladder Cancer Drug Trials 03/22/17 San Francisco
SutroVax Lands $64M From Roche, Others to Back Vaccine Studies 03/21/17 San Francisco
No Pain, No High: Nektar’s Opioid Drug Hits Trial Goals, Lifts Shares 03/20/17 San Francisco
For $140M, PTC Gets Duchenne Drug and a Pricing Controversy from Marathon 03/16/17 New York
Proteon Therapeutics Plans Path Forward for Blood Vessel Drug 03/16/17 Boston
With FDA’s Blessing, Seres Preps New “Pivotal” Microbiome Drug Trial 03/16/17 Boston
Myomo, a Robotic Arm Brace Maker, Aims to Raise $15M in “Mini-IPO” 03/15/17 Boston
Scott Gottlieb On Tap to Lead FDA, and Biopharma Exhales 03/10/17 National
Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain Cancer 03/10/17 San Diego
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More 03/10/17 National
Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics 03/08/17 Boston
Bluegrass Vascular Gets Funding, Signs Distribution Deal With Merit 03/06/17 Texas
Seattle Genetics to Resume Leukemia Drug Trials After FDA Lifts Hold 03/06/17 Seattle
Ingeneron Gets $20M From Sanford Health For Stem Cell Treatment 03/06/17 Texas
VenBio-Backed Directors Wrest Control of Immunomedics Board 03/03/17 New York
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More 03/03/17 National
No Details Yet, But Genentech Drug Combo Wins in Big Breast Cancer Study 03/02/17 San Francisco
Evestra Signs Deal with Glemark for Generic Version of NuvaRing 03/01/17 Texas
After Trial Deaths, Juno Pivots and Scraps Lead CAR-T Therapy 03/01/17 Seattle
Former FDA Commissioners Califf, McClellan Talk Healthcare’s Future 03/01/17 National
FDA Approves Houston Biotech Lexicon’s Carcinoid Syndrome Diarrhea Drug 02/28/17 Texas
With Eye On FDA, Kite Says CAR-T For Lymphoma Holds Up After 6 Months 02/28/17 National
Blood Pressure Drug Trial Results Lift La Jolla Pharma Shares 02/27/17 San Diego
Cempra Soars on Drug’s Potential to Treat MRSA, Other Infections 02/24/17 Raleigh Durham
Trump Policies, Paperwork, & More: Advice for Startup Founders 02/24/17 Wisconsin
Page 2 of 59 « previous page · next page »